NCT01831960View on ClinicalTrials.gov

An Evaluation of the Adrenal Suppression Potential and Pharmacokinetic Properties of CB-03-01 Cream in Subjects With Acne Vulgaris

PHASE2CompletedINTERVENTIONAL
Enrollment

42

Participants

Timeline

Start Date

April 30, 2013

Primary Completion Date

November 30, 2013

Study Completion Date

November 30, 2013

Conditions
Acne Vulgaris
Interventions
DRUG

cortexolone 17α-propionate

Trial Locations (3)

Unknown

Northwest Clinical Trials, Inc., Boise

Shideler Clinical Research Center, Carmel

Michigan Center for Research Corp., Clinton Township

Sponsors
All Listed Sponsors
lead

Intrepid Therapeutics, Inc.

INDUSTRY